 |
Bacillus subtilis oxalate decarboxylase |
|---|---|
| Trade Name | |
| Orphan Indication | Pediatric hyperoxaluria |
| USA Market Approval | USA |
| USA Designation Date | 2016-02-29 00:00:00 |
| Sponsor | Allena Pharmaceuticals, Inc.;1 Executive Park Drive, Suite 202;Newton, Massachusetts, 02462 |
